FDA Brief

Company record

DFI Co., Ltd.

1 FDA warning letter since 2023 and 7 recalls in the last 12 months.

Get an email the day FDA posts anything new about DFI Co., Ltd..

Warning letters

  1. DFI Co., Ltd.

    CGMP/QSR/Medical Devices/Adulterated

Recalls

ReportedClassFirmProduct and reason
May 13 Class II DFI Co., Ltd.
Device
One Step K in vitro diagnostic test REF: 81A4
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
Uric Acid in vitro diagnostic test REF: 31H0P
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
QUCARE Total Cholesterol in vitro diagnostic test REF: 6407
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step P in vitro diagnostic test REF: 8194
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step pH in vitro diagnostic test REF: 31I4P
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step 10A in vitro diagnostic test
The devices were distributed without required FDA premarket clearance or approval.
May 13 Class II DFI Co., Ltd.
Device
One Step UTI in vitro diagnostic test REF: 3374
The devices were distributed without required FDA premarket clearance or approval.